Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/58350
Full metadata record
DC FieldValueLanguage
dc.contributor.authorIsabella R. Strauben_US
dc.contributor.authorAlexandre Janeren_US
dc.contributor.authorWoranontee Weraarpachaien_US
dc.contributor.authorLorne Zinmanen_US
dc.contributor.authorJanice Robertsonen_US
dc.contributor.authorEkaterina Rogaevaen_US
dc.contributor.authorEric A. Shoubridgeen_US
dc.date.accessioned2018-09-05T04:23:01Z-
dc.date.available2018-09-05T04:23:01Z-
dc.date.issued2018-01-01en_US
dc.identifier.issn14602083en_US
dc.identifier.issn09646906en_US
dc.identifier.other2-s2.0-85040530689en_US
dc.identifier.other10.1093/hmg/ddx393en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85040530689&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/58350-
dc.description.abstract© The Author 2017. Published by Oxford University Press. All rights reserved. Coiled-helix coiled-helix domain containing protein 10 (CHCHD10) and its paralogue CHCHD2 belong to a family of twin CX9C motif proteins, most of which localize to the intermembrane space of mitochondria. Dominant mutations in CHCHD10 cause amyotrophic lateral sclerosis (ALS)/frontotemporal dementia, and mutations in CHCHD2 have been associated with Parkinson's disease, but the function of these proteins remains unknown. Here we show that the p.R15L CHCHD10 variant in ALS patient fibroblasts destabilizes the protein, leading to a defect in the assembly of Complex I, impaired cellular respiration, mitochondrial hyperfusion, an increase in the steady-state level of CHCHD2, and a severe proliferation defect on galactose, a substrate that forces cells to synthesize virtually all of their ATP aerobically. CHCHD10 and CHCHD2 appeared together in distinct foci by immunofluorescence analysis and could be quantitatively immunoprecipitated with antibodies against either protein. Blue native polyacrylamide gel electrophoresis analyses showed that both proteins migrated in a high molecular weight complex (220 kDa) in control cells, which was, however, absent in patient cells. CHCHD10 and CHCHD2 levels increased markedly in control cells in galactose medium, a response that was dampened in patient cells, and a new complex (40 kDa) appeared in both control and patient cells cultured in galactose. Re-entry of patient cells into the cell cycle, which occurred after prolonged culture in galactose, was associated with a marked increase in Complex I, and restoration of the oxygen consumption defect. Our results indicate that CHCHD10-CHCHD2 complexes are necessary for efficient mitochondrial respiration, and support a role for mitochondrial dysfunction in some patients with ALS.en_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectMedicineen_US
dc.titleLoss of CHCHD10-CHCHD2 complexes required for respiration underlies the pathogenicity of a CHCHD10 mutation in ALSen_US
dc.typeJournalen_US
article.title.sourcetitleHuman Molecular Geneticsen_US
article.volume27en_US
article.stream.affiliationsMcGill Universityen_US
article.stream.affiliationsMcGill University, Montreal Neurological Institute and Hospitalen_US
article.stream.affiliationsChiang Mai Universityen_US
article.stream.affiliationsSunnybrook Health Sciences Centreen_US
article.stream.affiliationsUniversity of Torontoen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.